These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8938527)

  • 21. Purging of human breast cancer cells from stem cell products with an adenovirus containing p53.
    Hirai M; Kelsey LS; Vaillancourt M; Maneval DC; Watanabe T; Talmadge JE
    Cancer Gene Ther; 2000 Feb; 7(2):197-206. PubMed ID: 10770627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous bone marrow support and bone disease in metastatic breast cancer.
    Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
    Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide mobilization of peripheral blood stem cells for use in autologous transplantation after high-dose chemotherapy: clinical results in patients with contaminated or hypocellular bone marrow.
    Myers SE; Williams SF; Geller RB
    J Hematother; 1992; 1(1):27-33. PubMed ID: 1365014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal residual disease in autologous hematopoietic harvests from breast cancer patients.
    Spyridonidis A; Bernhardt W; Fetscher S; Behringer D; Mertelsmann R; Henschler R
    Ann Oncol; 1998 Aug; 9(8):821-6. PubMed ID: 9789603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.
    Silva MR; Parreira A; Ascensão JL
    Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
    Han X; Shi Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High dose chemotherapy and hematopoietic progenitor cell transplantation for breast cancer.
    Pedrazzoli P; Tarenzi E; Tullio C; Colosini G; Siena S
    J Chemother; 2004 Nov; 16 Suppl 4():108-11. PubMed ID: 15688624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates.
    Meehan KR; Verma UN; Cahill R; Frankel S; Areman EM; Sacher RA; Foelber R; Rajagopal C; Gehan EA; Lippman ME; Mazumder A
    Bone Marrow Transplant; 1997 Oct; 20(8):643-51. PubMed ID: 9383227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy.
    Pedrazzoli P; Battaglia M; Da Prada GA; Lanza A; Cuomo A; Bertolini F; Pavesi L; Robustelli della Cuna G
    Bone Marrow Transplant; 1997 Jul; 20(2):167-9. PubMed ID: 9244422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a clinically applicable high-speed flow cytometer for the isolation of transplantable human hematopoietic stem cells.
    Sasaki DT; Tichenor EH; Lopez F; Combs J; Uchida N; Smith CR; Stokdijk W; Vardanega M; Buckle AM; Chen B
    J Hematother; 1995 Dec; 4(6):503-14. PubMed ID: 8846010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric quantitation of circulating hematopoietic progenitor cells in breast cancer patients on chemotherapy.
    Read EJ; O'Shaughnessy JA; Yu MY; Cottler-Fox M; Denicoff AM; Cowan KH; Gress RE
    Prog Clin Biol Res; 1992; 377():523-30. PubMed ID: 1279720
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
    Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose therapy for treatment of breast cancer.
    Anderson-Reitz L; Mechling BE; Hertz SL
    Nurse Pract Forum; 1999 Sep; 10(3):154-8. PubMed ID: 10614360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
    Shpall EJ; Bast RC; Joines WT; Jones RB; Anderson I; Johnston C; Eggleston S; Tepperberg M; Edwards S; Peters WP
    Bone Marrow Transplant; 1991 Feb; 7(2):145-51. PubMed ID: 2049558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A semi-automated process for antibody sensitization and washing of mononuclear cells prior to CD34+ cell selection.
    Cipolone KM; Carter CS; Yu M; Cottler-Fox M
    Prog Clin Biol Res; 1994; 389():667-73. PubMed ID: 7535463
    [No Abstract]   [Full Text] [Related]  

  • 37. Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.
    Glück S; Ross AA; Layton TJ; Ostrander AB; Goldstein LC; Porter K; Ho AD
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):316-23. PubMed ID: 9502299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A semiautomated technique for volume reduction of stem cell suspensions for autotransplantation.
    Ayello J; Hesdorffer C; Reiss RF
    J Hematother; 1995 Dec; 4(6):545-9. PubMed ID: 8846015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a novel automated protocol for the collection of peripheral blood stem cells mobilized with chemotherapy or chemotherapy plus G-CSF using the Fresenius AS104 cell separator.
    Pierelli L; Menichella G; Paoloni A; Vittori M; Foddai ML; Serafini R; Rumi C; Mitschulat H; Rossi PL; Scambia G
    J Hematother; 1993; 2(2):145-53. PubMed ID: 7522877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor-derived fat tissue as a source for lipofilling after allogeneic hematopoietic cell transplantation.
    Lapid O; van der Horst CM; Kater AP
    J Clin Oncol; 2012 Jun; 30(17):e154-5. PubMed ID: 22547590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.